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Abstract 
Steroidal sulfate esters play a central role in many physiological processes. They serve as the reservoir 
for endogenous sex hormones and form a significant fraction of the steroid metabolite pool. The 
analysis of steroid sulfates is thus essential in fields such as medical science and sports drug testing. 
Although the direct detection of steroid sulfates can be readily achieved using liquid chromatography-
mass spectrometry, many analytical approaches, including gas chromatography-mass spectrometry, 
are hampered due to the lack of suitable enzymatic or chemical methods for sulfate ester hydrolysis 
prior to analysis. Enhanced methods of steroid sulfate hydrolysis would expand analytical possibilities 
for the study of these widely occurring metabolites. The arylsulfatase from Pseudomonas aeruginosa 
(PaS) is a purified enzyme capable of hydrolysing steroid sulfates. However, this enzyme requires 
improvement to hydrolytic activity and substrate scope in order to be useful in analytical applications. 
These improvements were sought by applying semi-rational design to mutate amino acid residues 
neighbouring the enzyme active site. Mutagenesis was implemented on both single and multiple 
residue sites. Screening by UPLC-MS was performed to test the steroid sulfate hydrolysis activity of 
these mutant libraries against testosterone sulfate. This approach revealed the steroid sulfate binding 
pocket and resulted in three mutants that showed an improvement in catalytic efficiency (Vmax/KM) of 
more than 150 times that of wild-type PaS. The substrate scope of PaS was expanded and a modest 
increase in thermostability was observed. Finally, molecular dynamics simulations of enzyme-
substrate complexes were used to provide qualitative insight into the structural origin of the observed 
effects. 
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1 Introduction 
Steroids and their derivatives comprise a large family of compounds with many roles in biology and 
medicine. Steroid compounds abound as lipids, hormones and natural products. Their importance is 
reflected in many therapeutic interventions that target steroidal biosynthesis or signalling, and the 
continued prevalence of steroid abuse as a major problem for world sport and society at large. Within 
the larger steroid family, steroid sulfate esters play a central role, serving as the reservoir for 
endogenous sex hormones and forming a significant fraction of the steroid metabolite pool.1 
Therefore, the analysis of steroid sulfates is essential in many fields of scientific endeavour including 
medical science and sports drug testing. Recent developments in anti-doping science include a 
growing emphasis on the analysis of steroid sulfate metabolites. The analysis of steroid sulfates has 
been shown to increase the detection times for a range of steroid agents2-8 and can also be used to 
distinguish between endogenous steroids and otherwise identical exogenously administered steroids 
of synthetic origin.4,9-13  
Although the direct detection of steroid sulfates can be readily achieved using liquid chromatography-
mass spectrometry in combination with electrospray ionisation,14 many analytical approaches are 
hampered due to the lack of suitable enzymatic or chemical methods for sulfate ester hydrolysis prior 
to analysis.15 The hydrolysis of steroid sulfates is frequently required to confirm the identity of 
steroidal analytes against available reference materials, or to meet stringent sample preparation 
requirements for techniques such as gas chromatography-isotope ratio mass spectrometry. Acid 
catalysed solvolysis is a general method of hydrolysis for both steroid sulfate and glucuronide phase II 
conjugates. However, this method is often unsuitable for steroid analysis since it can degrade analytes 
of interest and generate a more complicated analytical matrix.15,16 For these reasons, the mild and 
selective hydrolysis of steroid glucuronides is typically performed enzymatically using E. coli β-
glucuronidase15 and this process is mandated within the steroid module of the Athlete Biological 
Passport developed by the World Anti-Doping Agency.17 In a similar manner, general methods for the 
mild and selective enzyme hydrolysis of sulfate esters would provide significant benefits for the 
analysis of steroid sulfates. 
Arylsulfatase enzymes (EC 3.1.6.1) are present in all kingdoms of life and catalyse the hydrolysis of a 
diverse range of sulfate esters.18 The nomenclature reflects the relative ease with which aromatic 
sulfate esters are hydrolysed. However, alkyl sulfate esters such as steroid sulfates are also substrates 
for this enzyme family. The arylsulfatases make use of an active site metal ion and a rare post-
translational modification, where a cysteine or a serine residue is oxidised to formyl glycine (FGly) 
mediated by separate families of formyl glycine generating enzymes.19 The signature sequence, C/S-
X-P-X-R is conserved throughout the entire enzyme class and is important in directing the post-
translational modification. Mechanistic proposals for sulfate ester hydrolysis18,20,21 typically employ 
the post-translationally modified FGly in its hydrated form (FGH) as the catalytic nucleophile 
responsible for sulfate ester S-O bond cleavage. The complete catalytic cycle is proposed to involve a 
transesterification-elimination-hydration sequence.  
Several sulfatases are commercially available, but none of them offer a broad range of activity for 
steroid sulfate hydrolysis.22 The partially purified sulfatase preparation from Helix pomatia (HpS) 
offers the greatest range of steroid sulfatase activity, but does not consist of a single known sulfatase 
enzyme23 and has been reported to display alternative enzyme activities.15 In contrast, the 
Pseudomonas aeruginosa arylsulfatase (PaS) is an easily purified bacterial enzyme that has 
comparable steroid sulfatase activity (Figure 1) with the commercially available HpS.22,24 However, the 
slow rates of the hydrolysis of β-configured steroid sulfates and almost negligible sulfatase activity 
with α-configured steroid sulfates indicate that PaS is not a universal steroid sulfatase suitable for 
analytical applications. Despite this, PaS represents a good starting point for engineering a steroid 
sulfatase since it is efficiently produced in E. coli as a highly stable enzyme22 and has been studied by 
X-ray crystallography.21 Furthermore, PaS has been reported as a catalytically promiscuous enzyme,25-
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27 an attribute which has been argued to be important in steering the functional evolution of 
enzymes.28-30  
 
Figure 1: Hydrolysis of testosterone sulfate (TS) to testosterone (T) by wild-type Pseudomonas 
aeruginosa arylsulfatase (WT-PaS). 
This study aimed to improve the catalytic activity of PaS for the hydrolysis of steroid sulfates such as 
testosterone sulfate (TS) and to improve the substrate scope while maintaining the stability of the 
enzyme. We followed a semi-rational approach where the residues were selected based on 
examination of the published crystal structure.21 Five residues were initially subjected to saturation 
mutagenesis followed by mutating small groups of neighbouring residues simultaneously. Beneficial 
mutations were then shuffled to find PaS variants with improved efficiency for TS hydrolysis. Improved 
mutants also displayed expanded substrate scope and, in some cases, greater enzyme thermostability. 
Finally, molecular dynamics simulations of enzyme-substrate complexes were employed to 
qualitatively understand the underlying structural basis for the observed improvements. In 
combination, these data provide a baseline for the future engineering of PaS to enhance its activity 
towards other steroid sulfates. 
 
2 Results  
Our effort to generate an enzyme with improved catalytic efficiency for the hydrolysis of testosterone 
sulfate (TS) was based on the crystallographic structure resolved by Boltes et al. (PDB ID: 1HDH).21 The 
catalytic formylglycine hydrate and calcium ion sit at the deepest part of a long and irregularly-shaped 
cleft (Figure 2). Visual inspection of this cleft revealed several residues that defined a narrow entry 
zone for potential steroid sulfate substrates. This included K330, one of several residues that was not 
fully resolved in the reported X-ray structure. Bulky residues that restricted access to the catalytic site 
were suggested as ideal targets for mutagenesis. To increase the chance of finding useful mutations, 
residues that were known to be involved in the catalytic mechanism or were highly conserved were 
excluded. Residue conservation was evaluated using the ConSurf web-based server to analyse a 
multiple sequence alignment of nearly 150 distinct sulfatase primary sequences (Supporting 
Information S1.1.1).31,32 As a result of these inspections five residues spanning the active site cleft 
were selected for mutagenesis: R155, F328, F331, F463, and K330 (Figure 2). 
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Figure 2: Molecular surface of the PaS X-ray crystal structure (PDB ID: 1HDH),21 showing the active 
site cleft. The catalytic formylglycine hydrate residue (sticks, obscured) and calcium ion (sphere) are 
shown in green. Residues selected for mutagenesis in the active site cleft are labelled and 
highlighted as magenta sticks. The K330 sidechain that was not resolved in the X-ray crystal 
structure was introduced using the PyMOL mutagenesis wizard for visualization purposes. 
2.1 Site saturation mutagenesis (SSM) libraries 
The five residues shown in Figure 2, F328, F463, F331, K330 and R155, were mutated in turn (S1.1.2) 
using the primers listed in the supporting information (Table S1, Table S2), to produce five site-
saturation mutant libraries (SSM 1-5). For each SSM library, and subsequent libraries, variants were 
randomly selected to evaluate the diversity of codons by DNA sequencing. The number of mutants to 
be screened for TS hydrolysis from each SSM library was calculated such that each of the possible 
mutant codons had more than 95% probability of being tested (Table S3). To maximise the likelihood 
of obtaining improved mutants for steroid sulfate hydrolysis, a medium throughput 96 well plate-
based UPLC-MS screening strategy was used to monitor hydrolysis of TS to testosterone (S1.2, S1.3). 
Alternative high-throughput screens based on the hydrolysis of chromogenic or fluorogenic 
substrates, such as para-nitrophenyl sulfate (pNPS) or 4-methylumbelliferone sulfate, would be 
unsuitable for finding the desired improvements. Hydrolysis of these substrates generates delocalised 
aromatic oxy-anions that are stable (and so more easily detected) and would not necessary require 
general acid catalysis during hydrolysis. Kinetic and computational evidence suggest the hydrolysis of 
pNPS is not mediated by a general acid.33,34 This is contrary to steroid sulfates, that would require a 
general acid to generate an aliphatic alcohol leaving group for efficient hydrolysis. In this way, TS was 
an ideal substrate for screening efforts: it represents the most challenging steroid sulfate for wild-type 
PaS hydrolysis where the product can be readily quantified. This provided clear scope for the catalytic 
improvement of PaS.  
Following LC-MS screening, two of the five SSM libraries yielded three PaS variants with improved TS 
hydrolysis rates: proline or threonine at position 155 (R155P or R155T) or valine at 330 (K330V). In 
contrast with residues at 155 and 330, mutating the three phenylalanine residues at 328, 331 and 463 
did not yield any beneficial mutants.  
2.2 Combined mutants 
Two PaS variants were prepared (S1.1.3) to test the effect of combining the beneficial mutations, 
R155P/K330V (PV-PaS) and R155T/K330V (TV-PaS). Each of the single and double mutants, together 
with wild-type PaS (WT-PaS), were purified (S1.4) with hexa-histidine C-terminal tags by Ni-NTA 
affinity chromatography to study enzyme kinetics (S1.5.1, Figure S1, Table 1). Initial rate kinetic data 
was fitted to the Michaelis-Menten equation for a scheme involving binding and catalysis. 
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All improved PaS variants exhibit a significant increase in Vmax value with the two double mutants 
exhibiting more than three times wild-type Vmax value (Table 1). No improvements were observed in 
KM value as a result of single mutations at 155, although K330V significantly increased KM. Mutations 
of both sites together showed that their effects on TS hydrolysis kinetics were not independent; they 
were synergistic in accordance with their close proximity in the crystal structure.21 The PV-PaS double 
mutant showed a significant improvement in substrate affinity with 62% of the wild-type KM, whereas 
TV-PaS was the opposite with approximately twice the KM value of wild-type. Overall, PV-PaS offered 
the best result from the first set of mutations with the highest Vmax/KM value: 5.6 times that of WT-
PaS. Therefore, the PV-PaS double mutant was selected to be carried forward as template for the 
following rounds of engineering. 
Table 1: Kinetic parameters for TS hydrolysis by selected PaS variants. The respective mutations, the 
library they were found in, template used and kinetic parameters determined over an initial TS 
concentration from 2.5 – 320 µM at pH 9 (50 mM Tris acetate) and 37 °C. 
PaS enzyme Mutational residue Library Template Kinetic parametersa 
155 156 157 158 160 325 330 KM 
[µM] 
Vmax 
[10-2 
µmol min-1 g-1] 
(Vmax/KM) 
[10-3 
L g-1 min-1] 
WT-PaS R I L K T L K - - 35 ± 5 9.7 ± 0.4 2.8 ± 0.4 
V-PaS R I L K T L V SSM 4 WT-PaS 53 ± 4 16.3 ± 0.4 3.1 ± 0.3 
P-PaS P I L K T L K SSM 5 WT-PaS 36 ± 4 29 ± 1 8.2 ± 1.1 
T-PaS T I L K T L K SSM 5 WT-PaS 37 ± 3 24.0 ± 0.6 6.5 ± 0.5 
PV-PaS P I L K T L V - - 22 ± 1 35.3 ± 0.6 16 ± 1 
TV-PaS T I L K T L V - - 88 ± 10 47 ± 2 5.4 ± 0.6 
PVFV-PaS P V L K T F V MSM 1 PV-PaS 38 ± 2 343 ± 28 91 ± 9 
PVIV-PaS P I V I T L V MSM 2 PV-PaS 4.5 ± 0.2 207 ± 7 463 ± 26 
VVIV-PaS R V V I T L V Shuffled WT- or PV-PaS 9.6 ± 0.5 411 ± 19 427 ± 30 
LEF-PaS R L L E T F K Shuffled WT- or PV-PaS 17 ± 1 743 ± 35 427 ± 32 
a These estimates are the mean ± the standard deviation from three experiments. 
2.3 Multiple site mutagenesis (MSM) 
The initial mutagenesis work had succeeded in delivering modest improvements by mutating residues 
individually. However, the greatest improvements were afforded by finding the best combination of 
the two mutations. The synergy between mutations is regularly observed by protein engineers and is 
often accommodated in experiment design. Simultaneous mutation of residues has featured in 
protocols such as the “combinatorial active-site saturation test”35 or “combinatorial codon 
mutagenesis”36 The success of mutagenesis lies in obtaining sufficient amino acid diversity at the 
targeted site so that sequence space is adequately covered. Nevertheless, due to the limitations 
inherent in UPLC-MS screening, it was necessary to compromise coverage to limit library size. The 
basis for our reduction in available combinations for MSM was to target a range of hydrophobic 
residues in order to increase the favourable interactions with a hydrophobic substrate (NYS codon, 
N=A/T/G/C, Y=C/T, S=G/C). Assuming full coverage, this degeneracy allowed for all hydrophobic 
residues except tryptophan and glycine, and included serine and threonine. Tryptophan was not of 
interest as it is a bulkier residue than the original residues. However, the option for glycine was 
sacrificed in order to use a simple degenerate codon for library preparation. Using this approach an 
acceptable 80% coverage for the amino acid diversity was predicted for primary screening of the MSM 
1 and MSM 2 libraries (Table S3). In contrast >95% coverage was expected for primary screening of 
the MSM 3 and shuffled libraries. 
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2.3.1 MSM 1 
The first set of residues for multiple site mutagenesis (MSM 1) were: I156, L325, and F331 (S1.1.4, 
Table S3). They were selected as neighbours of the successfully mutated sites (R155 and K330) and 
because they appeared to project into the substrate binding pocket (Figure 3A). The best mutant in 
hand, PV-PaS, was used as the template for this library of variants. One residue, F331, had already 
been mutated (SSM 3) in isolation without success, but it was hypothesised that simultaneous 
mutations at neighbouring residues on top of the mutations in the template PV-PaS might support a 
useful change.  
Primary screening of 1728 colonies was performed with 100 µM TS and those that gave rise to greater 
testosterone release than PV-PaS were tested in the secondary screen (92 clones). Tests with purified 
enzymes confirmed that four beneficial PaS variants had greater activity than template PV-PaS (Table 
S4). The kinetic parameters of the best mutant PVFV-PaS (Table 1), containing mutations I156V and 
L325F in addition to R155P and K330V, showed a Vmax/KM value for TS that was 33 times that of WT-
PaS.  All beneficial mutants observed in this library retained the original F331.  
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Figure 3: The residues selected for mutagenesis in each MSM library are shown with side chains as 
green sticks and labelled in black for MSM 1 (A), MSM 2 (B), MSM 3 (C). The substrate (TS) is shown 
in dark grey balls and sticks. The models are starting structures for molecular dynamics simulations 
and are derived from the X-ray crystal structure of wild-type PaS (PDB ID: 1HDH)21 with TS manually 
placed in the active site. The active site calcium ion responsible for sulfate ester binding is shown as 
a green sphere. The locations of template mutations are shown and labelled in blue.  
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2.3.2 MSM 2 
The second round of MSM targeted I156, L157, K158 and T160 (Figure 3B) with PV-PaS as the template 
(S1.1.5, Table S3). These residues were on the short helix where two other beneficial mutations (155P 
and 156V) were found. It was reasoned that further optimisation of this helix may be possible by 
finding the best combination of residues. To minimise library size, residue 159 was not targeted for 
mutagenesis since this wild-type glycine residue directly faced the active site and an enforced change 
to larger residues was thus expected to be deleterious. The MSM 2 library was prepared by using the 
NYS degenerate codon at positions 157, 158, and 160, whereas position 156 was targeted to the three 
residues found in the best MSM 1 mutants (Table S4). The degenerate codon at position 156 was VTT 
(where V = A/G/C) to allow for isoleucine, valine or leucine. Greater stringency was applied for the 
screening of the MSM 2 library by using 20 µM TS; one fifth the previous concentration. This brought 
the substrate concentration below the wild-type KM value so as to discover mutants with greater 
affinity for TS; necessary for the samples of low concentration typically encountered in analytical 
applications. With primary screening of 4800 colonies and subsequent secondary (118 clones) and 
tertiary (20 clones) screens, three mutants were identified with greater activity than the PV-PaS 
template (Table S4). The best mutant, PVIV-PaS, which contained the template mutations together 
with I156, L157V and K158I, exhibited a Vmax/KM value that was 167 times greater than the WT-PaS 
(Table 1).  
2.3.3 MSM 3 
The targets for MSM 3 focused on two residues on the opposite side of the binding pocket compared 
with previous sites: M72 and E74 (Figure 3C). These residues were in close proximity to the catalytic 
residues and were of interest because they provide some bulk to the substrate binding pocket. In this 
case PVFV-PaS (from MSM 1) was used as the template and included screening of the possible 
variations with NYS degeneracy and a > 95% probability of all variants being tested (Table S3). 
Mutating these two residues (S1.1.5) resulted in a library of inactive PaS variants, suggesting that these 
residues may directly or indirectly be involved in enzyme catalysis. Importantly, the NYS degenerate 
codon allowed for methionine, but not glutamate residues, suggesting that it was mutation of E74 
that led to the dramatic loss of activity. 
2.4 Shuffled library 
The beneficial mutations found in the improved PaS variants (Table S4) were shuffled to test for 
further improvements in catalytic activity (S1.1.6). This involved mutations at seven residues (Table 
S5), with WT-PaS or PV-PaS as the template. Suitable degenerate codons were available at all positions 
with the exception of position 158. Here, the RWA degenerate codon included glutamate (E) in 
addition to the targeted amino acids. From a primary screen of 1536 clones, six PaS variants were 
discovered with greater initial hydrolysis rates for TS hydrolysis that exceeded PVIV-PaS (Table S4). 
Surprisingly, two of the top mutants incorporated a K158E substitution. Two mutants, one without 
K158E substitution, VVIV-PaS, and one with K158E substitution, LEF-PaS, were selected for further 
characterization. Kinetics studies were performed on these mutants and revealed that both Vmax and 
KM values had increased such that their Vmax/KM value was similar to that of PVIV (Table 1). 
2.5 The pH dependence  
The optimum pH value for TS hydrolysis by WT-PaS was determined over a range from pH 5 to 9 as 
described in section S1.5.2. The pH profile for TS hydrolysis shows an optimum Vmax/KM of pH 7.1 as 
shown in Figure 4. The KM for TS showed a broad minimum from pH 6.5 to 8.0 whereas the Vmax 
reached an optimum at pH 6.0 to 6.5 (Figure S2).  
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Figure 4: The pH profile of Vmax/KM for TS hydrolysis by WT-PaS at 20 °C. Points at each pH show the 
estimate from fitting the Michaelis-Menten equation to three replicates of eight TS concentrations 
from 2.5 to 320 µM. The error bars correspond to the combined standard error from estimates of 
Vmax and KM. The curve represents non-linear regression based on a model with two ionisable 
residues where productive substrate binding occurs when only one group is protonated.37 The 
ionisable residue pKa values are estimated as 5.9 ± 0.1 and 8.3 ± 0.1. The pH profiles for Vmax and KM 
are provided in the supporting information (Figure S2).  
2.6 Substrate scope at pH 7.5  
The hydrolytic activities of the best mutants from each level of mutagenesis were tested over four 
steroid sulfates, with the sulfate ester varying in stereochemistry and position (S1.5.3). The four 
substrates tested were TS, epiandrosterone sulfate (EAS), etiocholanolone sulfate (ECS) and 
epitestosterone sulfate (ETS) as shown in Figure 5 and free steroids were quantified against two 
calibrators containing the free steroids. They were tested at pH 7.5, compatible with the conditions 
typically used by analytical laboratories for enzyme hydrolysis of the glucuronide fraction with E. coli 
β-glucuronidase, and as the enzymes exhibit faster turnover closer to neutral pH for the hydrolysis of 
steroid sulfates (Figure 4). For this analysis, the enzyme concentration, substrate concentration and 
the reaction time used for the hydrolysis of α-configured steroid sulfates ECS and ETS was greater, 
given the low turnover of these substrates by PaS.  
 
Figure 5: Range of substrates tested. 
All mutants exhibited improved hydrolytic activity for TS, the substrate used in screening to uncover 
improved activity in this the enzyme engineering study (Table 1, Figure 6). The best mutant for TS may 
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not necessarily be the best for the other steroidal sulfate substrates. The WT-PaS enzyme hydrolyses 
one order of magnitude more EAS than TS which agrees well with the published results.22 Considering 
the low turnover of α-configured steroid sulfates, higher steroid sulfate and enzyme concentrations, 
and longer reaction times were required to observe detectable activity. As a result, the relative 
activities of α- and β-configured steroid sulfates may not be directly compared in Figure 6. Apart from 
TS hydrolysis showing remarkable improvements, ECS hydrolysis too showed enhanced activity with 
all mutants compared to WT-PaS. The large errors associated with ETS hydrolysis for all but PVFV-PaS 
(0.094 µM free steroid produced) indicate that the signals are within the level of noise. Taken together 
the results show that PVFV-PaS displays improved activity for the four substrates tested. Subsequent 
rounds of mutagenesis led to further improvement but also growing selectivity for the TS substrate 
used in screening. 
 
Figure 6: The activity profiles of WT-PaS and PaS mutants (S1.5.3). A) Free steroid produced by WT-
PaS. B) The activity profiles for the PaS mutants showing the free steroid produced for each 
substrate, normalized with respect to WT-PaS and presented on a logarithmic scale. The negative 
bars represent mutant activities less than the corresponding WT activity. The error bars correspond 
to the standard deviation from triplicates. 
2.7 Effect of temperature on enzyme activity and stability 
The thermostability of WT-PaS and the best variants from each library was tested in two ways: 
determining the temperature that causes 50% irreversible inactivation after 5 min (apparent melt 
temperature, Tmapp) at pH 7.5 or pH 9, or by measuring the half-life at 50 °C (T1/250 °C) at pH 9 (Table 2, 
S1.5.4, Figures S3 and S4). All six versions of PaS show higher Tmapp at pH 9 compared to that at pH 7.5. 
PVFV-PaS and LEF-PaS have c. a. 3.5 °C increase over WT-PaS for Tmapp at pH 9, but only PVFV-PaS 
retains improved thermostability at pH 7.5 (c. a. 3 °C higher than WT-PaS). As expected from these 
results, the PVFV-PaS mutant also displayed a longer half-life at 50 °C relative to WT-PaS (Table 2). 
Table 2: Thermal parameters for WT and mutant PaS variants 
 
 WT-PaS PV-PaS PVFV-PaS PVIV-PaS VVIV-PaS LEF-PaS 
Tmapp, pH 7.5 (°C) 51.2 ± 0.3 45.4 ± 0.7 54.3 ± 0.3 48.8 ± 1.4 47.9 ± 0.9 51.4 ± 0.2 
Tmapp, pH 9 (°C) 56.0 ± 0.1 50.2 ± 0.2 59.4 ± 0.2 53.3 ± 0.2 52.7 ± 0.2 59.5 ± 0.2 
T1/250 °C, pH 9 (h) 0.67 ± 0.04 0.12 ± 0.01 5.8 ± 0.2 0.6 ± 0.2 0.30 ± 0.04 1.2 ± 0.1 
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2.8 Hydrolysis of 16,16,17-d3-testosterone sulfate (d3-TS) in spiked urine 
The best TS-hydrolysing PaS variant, LEF-PaS, was tested in comparison with WT-PaS in a urine matrix. 
Human urine was spiked with 100, 200, or 300 ng mL-1 of d3-TS and incubated for 16 hours at pH 7.5 
and 37 °C with 10 µg mL-1 of the PaS variants (S1.5.5). The LEF-PaS mutant reached complete 
conversion to hydrolysed d3-testosterone whereas WT-PaS conversion was < 2% at all concentrations 
(Figure 7). 
 
Figure 7: The proportion of d3TS hydrolysed by WT-PaS or LEF-PaS (S1.5.5). The mean of triplicates 
is presented with error bars representing standard deviation. 
2.9 Molecular dynamics simulations  
Molecular dynamics simulations of wild-type and mutant PaS variants in complex with TS provided 
qualitative insight into the structural origins of the observed changes in activity (S1.6). One challenge 
when performing simulations of PaS is correctly assigning the protonation states of the key active site 
residues K113, H115, H211 and K375, as well as the active site FGH nucleophile (Figure S5). The FGH 
residue has been previously modelled in its anionic form in the related manganese-dependent 
phosphonate monoester hydrolases from Burkholderia caryophylli (BcPMH) and Rhizobium 
leguminosarum (RlPMH),38 although in the case of these enzymes, the structurally equivalent residues 
to K113 and H115 in PaS are a Tyr (Y105) and a Thr (T107), respectively, and so the issue of correctly 
assigning their protonation states does not arise. On the basis of semi-macroscopic pKa value 
calculations,33 a depressed pKa value for the K113 sidechain had been previously predicted, such that 
this residue was deprotonated in the resting state of the PaS Michaelis complex with pNPS. A similar 
prediction was made based on empirical pKa screening using PROPKA 3.1,39 using, the high-resolution 
(1.3 Å) structure of native PaS in complex with SO42- (PDB ID: 1HDH).21 This calculation suggested a 
slightly elevated pKa value of 7.8 for H115, and a correspondingly depressed pKa value of 8.4 for K113. 
When taking into account previous empirical valence bond (EVB) calculations on this system,33 K113 
was proposed as the general base that deprotonates the FGH catalytic nucleophile in the active site. 
In addition, while H211 has been suggested to act as a general-acid during sulfate transesterification 
by PaS,24,25 the estimated pKa value for this residue was low (0.94). While this pKa prediction is most 
likely an exaggeration due to the empirical nature of the calculation, nevertheless, a depressed pKa 
value is chemically logical given that this residue was located between both a positively charged lysine 
(K375) and the catalytic calcium ion. Therefore, it was proposed that K375 served as a general acid 
during the transesterification step, while H211 was present in its mono-protonated form, helping 
position the general acid K375, as in previous EVB models for both PaS33 as well as for BcPMH and 
RlPMH.38  
To validate these assumptions, 30 ns molecular dynamics simulations were performed of WT-PaS in 
complex with both a SO42- di-anion as in the crystal structure as well as the mono-anionic TS substrate, 
which was manually built onto the SO42- ion in the initial crystal structure. The resulting average values 
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of S-Onuc distance, Onuc-S-Olg angle, and other key interactions are shown in Table S6. From this table, 
it can be seen that the models that yield the most stable Michaelis complexes with the closest to in-
line geometries for nucleophilic substitution involve deprotonated FGH and H115 side chains, and 
protonated K113 and K375 side chains. In the case of H211, this residue appears to be preferentially 
di-protonated in the presence of the SO42- di-anion in order to offset the additional negative charge, 
but preferentially mono-protonated at π-N in the presence of the mono-anionic TS substrate, 
consistent with the depressed pKa value of this residue predicted by PROPKA.39 Based on these 
molecular dynamics simulations, as well as the insights from previous EVB simulations,33 a revised 
mechanism shown in Figure 8 was proposed, and used as a model for subsequent molecular dynamics 
simulations with TS. Notably, this preferred model (deprotonated FGH/H115/H211, protonated 
K113/K375) was an extreme representation of the mechanism shown in Figure 8, in which the FGH 
catalytic nucleophile was fully deprotonated by the K113 general base. This model, involving a single 
proton transfer between mechanistically coupled FGH and K113 catalytic residues was adopted as it 
yielded much more computationally stable Michaelis complexes (the average S-Onuc distances and 
Onuc-S-Olg angles, as well as other key interactions, are shown in Table S6). Once satisfied with the 
model for the Michaelis complex between PaS and the TS substrate, long-timescale molecular 
dynamics simulations of the Michaelis complexes of the wild-type enzyme, as well as the TV, PV, PVFV, 
LEF, PVIV and VVIV, variants were performed. A comparison of per-residue root mean square 
fluctuations (RMSF) of all backbone heavy atoms in our simulations of each enzyme variant is shown 
in Figures S6 and S7, and an analysis of all protein-substrate contacts is shown in Figures S8 and S9. 
Representative structures from each simulation have been uploaded to Dryad (available for download 
at DOI: To be provided after publication or prior to publication on request), so that interested readers 
can view the associated structural changes in 3D. 
 
Figure 8: The proposed transesterification-elimination-hydration of PaS, highlighting the role of 
E74 and H115 during elimination of the sulfated FGH intermediate.  
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2.9.1 TV-PaS, PV-PaS and WT-PaS 
For simplicity, the different variants were analyzed in pairs reflecting the step-wise evolutionary 
pathway associated with their discovery. The first such comparison involved TV-PaS and PV-PaS 
derived from combination of the beneficial mutations identified from site saturation mutagenesis 
(section 2.2). From the RMSF analysis, it was observed that TV-PaS was quite similar in flexibility to 
the wild-type enzyme (Figures S6 and S7). As shown in Table 1, TV-PaS showed an increase in the Vmax 
value, that is largely offset by an increase in the KM value. The lower affinity could, in part, be due to 
the loss of favorable enzyme-substrate interactions with K330 in the K330V mutation.  
In contrast, the PV-PaS variant was more flexible between residues 155-165 and 320-350, which 
included the R155P and K330V mutations (Figures S6 and S7). The importance of flexibility in enzyme 
evolution has been demonstrated in a number of previous computational studies,38,40 and this 
increased flexibility could here again be linked to the lower KM and higher Vmax values of this mutant, 
as it allows for better adaptation of the active site to the bulky steroid substrate. More substantial 
structural changes were also observed for PV-PaS involving substrate displacement and reshaping of 
the active site. Slightly increased enzyme-substrate contacts were observed between TS and K375 and 
A376. However, the most notable change in PV-PaS, compared to the wild-type, involved residues 
L324 and L325. Neither of these residues made contact with the substrate directly in WT-PaS or TV-
PaS (Figures S8 and S9), but in PV-PaS there were structural adaptations that allow for interactions 
with L324 and L325. This led to the formation of a “hydrophobic wall” on one side of the substrate, 
which blocked solvent penetration into the active site, as can be seen from comparison of the water 
densities and number of water molecules around the substrate (Figure 9, Figure S10). This could 
explain the reduction in KM value shown in Table 1 for PV-PaS compared to WT-PaS. In addition, the 
increased flexibility of PV-PaS mentioned above was accompanied by generally higher structural 
variability of the active site residues and substrate position, and could be linked to the increased 
catalytic efficiency observed.  
  
14 
 
 
Figure 9: Upper panel: key structural differences between the active sites of wild-type PaS (A), PV-
PaS (B) and TV-PaS (C) observed in the MD simulations of the three variants. Bottom panel: water 
density within 5Å of the substrate molecule (blue surface) in wild-type PaS (D), PV-PaS (E) and TV-
PaS (F) showing a hydrophobic wall formed in PV-PaS as a result of rearrangement of L324, L325 and 
F331 shown in the upper panel.  
2.9.2 PVFV-PaS, PVIV-PaS and PV-PaS 
Following from this, the PVFV and PVIV mutants were compared to PV-PaS, as these variants were 
constructed by MSM based on the PV-PaS template (section 2.3.1 and 2.3.2). These two variants 
displayed significant differences in activity, with PVFV showing 5.8-times higher Vmax/KM value, and 
PVIV-PaS showing 30-times higher Vmax/KM value, than PV-PaS (Table 1). Note however that these 
improvements were underpinned by changes in KM, which was slightly increased in PVFV-PaS, and 
more significantly decreased in PVIV-PaS, compared to PV-PaS. A comparison of the overall flexibility 
of the protein (Figures S6 and S7) shows, once again, changes in residues 155-165 and 320-350. 
Compared with PV-PaS, the residues in the 320-350 region become more flexible in PVFV-PaS and 
both regions become more rigid in PVIV-PaS. Interestingly, a comparison of the active site volumes of 
the different variants (Table S7 and Figure S11) showed that both PVFV-PaS and PVIV-PaS had larger 
active site volumes than PV-PaS, but all three variants had smaller active site volumes than WT-PaS. 
Notably, the effect of the “hydrophobic wall” observed in PV-PaS (Figure 9) had been lost or 
diminished in both mutants, and in the case of PVFV this could explain why the KM value increased to 
values closer to that of WT-PaS (Table 1). In terms of active site flexibility (as expressed by the standard 
deviations of the calculated volumes), PV-PaS and PVFV-PaS had a more flexible active site than PVIV-
PaS, and both variants were more flexible than WT-PaS (Figure S11 and Table S7).  
In PVFV-PaS the I156V mutation introduced a smaller amino acid sidechain and allowed the short 
helical region from 155-159 to approach the substrate more closely (Figures S8 and S9). The L325F 
mutation provided additional hydrophobic contacts with neighboring residues W212, W358 and the 
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newly introduced L156V (Figure 10). The PVFV-PaS mutant retained the high mobility of the PV-PaS 
parent (Figures S6 and S7) but was also (along with LEF PaS below) associated with higher 
thermostability (Table 2), in contrast with modest decreases in thermostability for PV-PaS, PVIV-PaS, 
and other variants. Thus, the L325F mutation provided additional stabilization for the flexible PVFV-
mutant. It should be noted that an inverse relationship between flexibility and thermostability may 
seem counterintuitive; however, both experimental and computational studies on several protein 
systems indicate that high stability and enhanced conformational flexibility are not necessarily 
mutually exclusive.41 The PVFV mutant also displayed the broadest substrate scope on the 
evolutionary pathway, with activity for the hydrolysis of α-configured steroid sulfates ESC and ETS 
(Figures 5 and 6) that was not observed for WT-PaS. There appears to be a correlation between active 
site volume, polar residues in the active site and active site flexibility, and the number of observed 
activities in alkaline phosphatases.38 It is therefore plausible that this increased flexibility leads to the 
broader substrate scope observed for the PVFV variant of PaS, that allows it, for example, to 
accommodate ECS (Figures 5 and 6). 
 
Figure 10: Overlay of three representative structures from the molecular dynamics simulation of 
PVFV-PaS in complex with TS. The structures depict the location of L325F in PVFV-PaS and its 
interactions with the neighbouring aromatic residues, specifically W212 and W358 observed in the 
majority of the simulation. The percentage values indicate the fraction of the simulation for which 
each structure is representative, as determined through RMSD-based clustering with average-
linkage algorithm. 
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In PVIV-PaS, the introduction of the β-branched residues, L157V and K158I mutations, led to reduced 
flexibility of the 155-165 and 320-350 regions (Figures S6 and S7), in the presence of the flexibility-
inducing R155P change. In addition, the K158I mutation eliminated a salt bridge between K158 and 
E151 located on the loop adjacent the alpha-helix containing the 158 residue. Associated with this, a 
slight repositioning of K330V and F331, leading to enhanced interactions with the substrate (Figures 
S8 and S9) that could in turn lead to the reduction in KM value observed for this variant. This mutant 
displayed a dramatic increase in the Vmax value and a significant decrease in KM value for TS hydrolysis 
(Table 1). However, in comparison to the PV-PaS template, the PVIV-PaS mutant was more specialized 
and showed reduced EAS and ECS hydrolysis activity (Figures 5 and 6). 
2.9.3 LEF-PaS and VVIV-PaS 
A final comparison was between VVIV-PaS and LEF-PaS, which were identified from a shuffled library 
of all beneficial mutants identified in earlier rounds (Section 2.4). Both mutants showed similar 
efficiency (~150 times WT-PaS) for TS hydrolysis to PVIV-PaS with modest increases in Vmax value offset 
by increases in KM value (Table 1). The two mutants were distinguished by different backbone 
flexibility, with VVIV-PaS showing a similar RMSF profile to WT-PaS and PVIV-PaS (Figures S6 and S7). 
In contrast, LEF-PaS showed slightly increased flexibility than WT-PaS in residues 155-165 and 320-
350, a pattern that was similar to, but attenuated from, that observed for PV-PaS and PVFV-PaS. 
Greater protein flexibility was also reflected in slightly higher variability of the active site volume for 
LEF-PaS compared to VVIV-PaS (Table S7 and Figure S11). Both proteins showed similar average active 
site volumes that were equal or slightly smaller than WT-PaS. Interestingly, the original combined 
mutation R155P reverted to R155 in both VVIV-PaS and LEF-PaS leading to increased interactions of 
this residue with the TS substrate in LEF-PaS (Figures S8 and S9). The LEF-PaS mutant was also 
observed to lose the K330V change introduced in the combined mutant.  
For LEF-PaS the I156L change was observed as beneficial in the MSM 1 and MSM 2 libraries, and the 
L325F mutation appeared in PVFV-PaS. Both positions were closely associated and packed together in 
a hydrophobic region of the protein adjacent to the active site. The L325F mutation (Figure 10) was 
previously associated with higher thermostability for PVFV-PaS that is also observed for the LEF-PaS 
variant (Table 2). Interestingly, LEF-PaS included the K158E mutation that was not previously identified 
as beneficial but arose by serendipity through the adoption of the RWA degenerate codon at this 
position. The K158E mutation eliminated the salt bridge between K158 and E151 located on the loop 
above the alpha-helix containing the 158 residue, resulting in the movement of the alpha-helix toward 
the substrate. The K158E residue was also observed (along with E74) to interact with R155, thereby 
forming a lid over the active site of the enzyme. Overall, the LEF-PaS mutant most closely resembled 
PVFV-PaS in terms of structure, flexibility and activity profile. In comparison to PVFV-PaS that showed 
the broadest substrate range, LEF-PaS showed greater specialization with enhanced TS hydrolysis but 
lower activity towards other substrates (Figures 5 and 6). This change in substrate profile can possibly 
be traced to the attenuated flexibility of LEF-PaS relative to PVFV-PaS (Figures S6 and S7). 
The VVIV-PaS shuffled mutant retained the L157V, K158I and K330V mutations of PVIV-PaS and varied 
only in the reversion of R155P to R155 discussed above and the introduction of an I156V change. The 
I156V mutation reduced contact of this residue with the TS substrate (Figures S8 and S9). In common 
with PVIV-PaS, the K158I mutation resulted in removal of the salt bridge between K158 and E151 
located on the loop adjacent the alpha-helix containing the 158 residue, which is accompanied by a 
repositioning of V330 and F331 residues towards the substrate (Figures S8 and S9). Overall, the VVIV-
PaS mutant most closely resembled PVIV-PaS in terms of structure, flexibility and activity profile. Both 
VVIV-PaS and PVIV-PaS mutants displayed similar activity profiles with enhanced TS hydrolysis but 
much smaller changes for EAS and ECS substrates (Figures 5 and 6). 
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3 Discussion 
The primary objective of this study was to engineer an improved enzyme for steroid sulfate hydrolysis. 
The PaS enzyme was selected as the candidate as it had recently been reported to display hydrolytic 
activity towards steroid sulfates.22 We applied semi-rational design for the process of protein 
engineering. Five rounds of SSM, three rounds of MSM and finally a shuffled library were created in 
the process of engineering PaS to discover improvements in the hydrolysis of testosterone sulfate. 
Together, three mutants were identified with ~150 times greater Vmax/KM value than WT-Pas (Table 1) 
and accompanied by a reduction in KM value. In addition, increases in substrate scope (Figure 5 and 6) 
and an improvement in thermostability were observed for some variants (Table 2). One of the leading 
mutants, LEF-PaS, exhibited improved performance relative to WT-PaS in tests performed in spiked 
human urine instead of a simple buffer, indicating that PaS variants are minimally affected by the 
inhibitory substances in a urine matrix (Figure 7). 
As a part of this study, molecular dynamics simulations of enzyme-substrate complexes were used to 
provide insight into the structural origin of the observed improvements. These simulations were based 
on well-established methods to model the catalytic metal ion, the FGH post-translational modification, 
and included new studies to evaluate the protonation state of key active site residues. Based on these 
simulations, the mutational pathway followed in this study can be briefly summarised as: the PV-PaS 
mutant introduced significant flexibility into the system and from this point two mutational 
trajectories emerged: (1) PV to PVFV to LEF, which was characterised by higher flexibility, higher Vmax 
value, higher thermostability and generally broader substrate scope; and (2) PV to PVIV to VVIV, which 
was characterised by lower flexibility, lower KM value and greater substrate specialization. From this 
analysis, it was clear that subtle changes in active site flexibility and the positioning of key residues 
could have a major impact on enzymatic activity and substrate scope. Significantly, previous 
experimental25,26,34,42,43 and computational33,44,45 studies have focused primarily on smaller model 
substrates, like pNPS, with activated leaving groups, whereas the present work examines larger steroid 
substrates of applied interest. Such substrates are notable for two reasons: they incorporate 
unstabilised leaving groups and so have a strict requirement for general acid catalysis during 
hydrolysis, and they are large and so more completely fill the PaS active site.  
Of the intermediates along this mutational pathway PVFV-PaS showed the broadest substrate range 
with significant increases in EAS, ECS and ETS hydrolysis (Figure 5 and 6). This correlated with the 
greatest enzyme flexibility and was important, as previous studies of WT-PaS showed no activity for 
ECS or ETS hydrolysis and commercially available HpS showed no activity for ETS.22 The substrate range 
improved early in the selection process, but continued screening for a single substrate proved 
detrimental to substrate range, as stated by You and Arnold46 ‘you get what you screen for’. This has 
often been observed with protein selection or directed evolution. The development of PVFV-PaS in 
this work that can hydrolyse the 17α-configured ETS is highly significant and provides a platform for 
further engineering efforts towards a universal steroid sulfatase enzyme for analytical applications.  
Although sequential rounds of mutagenesis typically afforded improvements in catalytic efficiency, 
the MSM 3 library provided an exception (section 2.3.3). The design of the MSM 3 library was inspired 
by the study of Kintses et. al.,47 where PaS was evolved for hydrolysis of a bulky aryl phosphonate 
ester. Several mutations to the 72-75 region were identified, in close proximity with the active site, 
that displayed improved hydrolytic activity or expression.47 In the current study, the M72 and E74 
residues were selected for randomization. The use of NYS codon degeneracy and screening to achieve 
>95% coverage of available amino acid diversity in the library ensured that mutants containing M72 
should be sampled, in contrast to E74 that is not included in the NYS codon. Unlike the positive results 
obtained by Kintses et. al.47 a library of inactive PaS variants was obtained for TS hydrolysis suggesting 
that the steroid sulfate hydrolysis presumably proceeds via a different catalytic pathway or has 
different requirements to the phosphonate ester hydrolysis by PaS. Based on inspection of the native 
PaS X-ray structure,21 it is possible that the negative charge on E74 stabilizes the adjacent H115 and 
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the two residues form an in-line interaction that facilitates deprotonation of the FGH for the 
elimination of the sulfated FGH intermediate, an arrangement reminiscent of the serine protease 
catalytic triad.48,49 Strongly attenuated pNPS hydrolysis activity was also observed for several 
independently prepared WT-PaS E74A/D/Q mutants (data not shown). The FGH residue had been 
observed in the X-ray structure of native PaS,21 resolving earlier uncertainty of surrounding key active 
site residues and supporting the proposed transesterification-elimination-hydration mechanism that 
pinpointed H115 as a general base responsible for the elimination step. This work implicates E74 as a 
key residue directing and activating H115 in this elimination sequence.18,21 The requirement for a 
charged residue such as E74 to interact with the general base for the elimination step does not appear 
to be universal for the sulfatase family. The X-ray crystal structures of the human arylsulfatase A20 or 
B50 enzymes do not contain a charged glutamate in this role and instead the histidine residue interacts 
with the backbone carbonyl of L92 or I114, respectively. An alignment of similar bacterial or fungal 
sulfatase genes (from UniRef 90 sequences) using ConSurf (S1.1.1) revealed that glutamate is common 
at residue 74 (corresponding to PaS residue numbering). ConSurf scored E74 in the top 40% of 
conserved residues. By comparison, the residues critical for metal ion coordination or catalysis are 
scored in the top 10%. The phylogenetic analysis of this alignment revealed that all PaS homologs from 
Mycobacterium, Pseudomonas or fungal species had a residue corresponding to E74. 
With respect to aryl phosphonate ester hydrolysis, the results of Kintses et al.47 identified a quadruple 
mutant M72L, E74G, M110I, K193Q with 6 times improvement in activity suggesting less sensitivity to 
the E74 residue for efficient catalysis. This observation may reflect different mechanistic pathways for 
phosphonate and sulfate ester hydrolysis. The accepted mechanism for the related alkaline 
phosphatase enzyme involves a metal coordinated serine as the catalytic nucleophile in the 
transesterification step.51,52 Enzyme turnover is then achieved by direct nucleophilic substitution of 
the serine phosphate intermediate by water. In contrast, the sulfated FGH intermediate in PaS is 
believed to hydrolyse by cleavage of the sulfate ester C-O bond with generation of FGly that then 
undergoes subsequent hydration to regenerate FGH. It has been observed that substituting the FGH 
residue with serine in human arylsulfatase A and B leads to mutants capable of transesterification to 
form a sulfated serine intermediate, but that this is stable at pH 5 and is hydrolysed only slowly at 
higher pH, so limiting enzyme turnover.53 Simple quantum mechanical computational models have 
identified the elimination of sulfated FGH as offering a lower energy pathway for sulfate ester 
hydrolysis than direct substitution at sulfur by an activated water molecule.34 These computational 
models also reveal that direct hydrolysis by an activated water molecule provides a competitive 
pathway for hydrolysis in the case of the FGH phosphate esters.34 Based on our experimental and 
computational analysis, a modified catalytic cycle for this enzyme is proposed (Figure 8), in which a 
catalytic nucleophile substitutes at the sulfate ester, with leaving group departure assisted by general 
acid catalysis from the K375 side chain. A mono-protonated H115 side chain then promotes 
elimination of the covalent sulfated FGH intermediate though hemiacetal cleavage. The mutational 
studies in this work serve to highlight the role of E74 in activating or pre-organizing the H115 general 
base responsible for elimination and so efficient sulfatase activity.  
At a practical level, the pH optimum (Vmax/KM) for TS hydrolysis by WT-PaS is near 7.1 (Figure 4) 
indicating that catalytic activity is determined by the ionisation of two active-site residues of pKa 
values of 5.9 ± 0.1 and 8.3 ± 0.1. This contrasts with the reported pH optimum (kcat/KM) for the 
hydrolysis of the model substrate para-methoxyphenyl sulfate of 7.9 with ionisable residue pKa values 
of 7.1 ± 0.2 and 8.7 ± 0.1.54 More significant differences in pH optimum were observed for the 
maximum initial hydrolysis rate (Vmax) by WT-PaS: greater than 954 for para-methoxyphenyl sulfate or 
8.955 for para-nitrocatechol sulfate, compared with a value near 6.0 for TS hydrolysis (Figure S2). The 
significant changes in pH optima may reflect the greater leaving group stability inherent in phenolic 
sulfate substrates. Computational studies on the hydrolysis of pNPS by WT-PaS have suggested that 
general acid catalysis is not involved in the key transesterification step.33 Further, kinetic studies for a 
range of different phenolic sulfates revealed little influence of leaving group on the rate of hydrolysis 
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(Vmax) suggesting the rate determining step of catalysis did not involve the leaving group.34 This points 
to elimination (or possibly hydration) as the rate determining step for these aromatic substrates such 
that the pH optimum observed would reflect the residues central to this process. The hydrolysis of 
steroidal sulfates that involve a non-stabilised saturated alcohol as leaving group would have a strict 
requirement for general acid catalysis. The large change in pH optimum observed for steroidal 
substrates may reflect a change in the rate determining step and so a change in the residues involved 
in rate limiting catalysis.  
Simultaneous to the development of this manuscript, two reports11,13 of work conducted within the 
World Anti-Doping Agency-accredited laboratory based at the Institute of Biochemistry, German Sport 
University, Cologne employed the PVFV-PaS mutant described for the first time in this work for sample 
preparation prior to Gas Chromatography-Carbon Isotope Ratio-Mass Spectrometry (GC-CIR-MS). In 
this complementary study, PVFV-PaS-mediated sample preparation enabled measurements of 
epiandrosterone liberated from epiandrosterone sulfate, a metabolite of testosterone and related 
androgenic anabolic steroids.12,13 The GC-CIR-MS technique provides an avenue to distinguish 
between endogenous steroid metabolites and those derived from otherwise identical exogenously 
administered steroids of synthetic origin. One conclusion of this study was that epiandrosterone 
sulfate served as a suitable marker for testosterone administration over a longer period than other 
reported markers suggesting that this method of analysis facilitated by PaS variants could improve the 
detection capabilities of anti-doping laboratories. Concordant with the results of this study, the PVFV-
PaS variant, with greater thermostability and activity for EAS hydrolysis (Figures 5 and 6), provided 
higher yields of free steroid during sample preparation than WT-PaS, highlighting the real world 
benefits of this mutagenesis study.11,13  
 
4 Conclusions 
The arylsulfatase from Pseudomonas aeruginosa was engineered by a semi-rational approach to 
discover mutants with improved catalytic activity for testosterone sulfate (TS) hydrolysis and to 
improve the substrate scope. After screening eight libraries for TS hydrolysis, mutants with significant 
improvements in catalytic activity, substrate affinity or both were obtained. The LEF-PaS exhibits the 
highest catalytic activity (Vmax) for TS hydrolysis with a catalytic efficiency (Vmax/KM) more than 150 
times than WT-PaS. However, the PVFV-PaS intermediate showed the broadest substrate range. 
Importantly, the detection of significant hydrolytic activity for the α-configured steroid sulfates 
derived from etiocholanolone and epitestosterone was a breakthrough. The PVFV-PaS mutant 
hydrolyses ECS at a rate two orders of magnitude higher than that of WT-PaS and represents a starting 
point for engineering a universal steroid sulfatase. In addition, the importance of E74 residue in the 
hydrolysis of steroid sulfates was uncovered and provides an avenue for further mechanistic 
investigation. As PaS variants are compatible with urine matrices under reaction conditions and pH 
similar to those employed during E. coli β-glucuronidase treatment, this study advances PaS as a 
valuable steroid sulfatase for analytical applications.  
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